• Policy
• Janssen's Sporanox is also expected to convert to imports
• by Lee, Tak-Sun Jun 22, 2021 05:50am

• Company
• PD-1 inhibitors enhance future value of anticancer treatment
• by Jun 22, 2021 05:50am

• Company
• Gifticon to MDs attending online sessions might be illegal
• by Kim, Jin-Gu Jun 22, 2021 05:50am

• Policy
• Quality issues alarmed the pharmaceutical industry
• by Jun 22, 2021 05:50am

• Policy
• Closing the opinion gap important for the generic '1+3 bill'
• by Lee, Jeong-Hwan Jun 21, 2021 05:51am

• Company
• Competition between PCSK9 Inhibitors has just begun
• by Eo, Yun-Ho Jun 21, 2021 05:51am

• Policy
• Gov will proactively improve system for severe psoriasis
• by Kim, Jung-Ju Jun 21, 2021 05:50am

• Policy
• Yuhan's Raboni-D has been licensed
• by Lee, Tak-Sun Jun 21, 2021 05:50am

• Product
• Tylenol sales increased 10 times to peak in May
• by Jun 21, 2021 05:50am

• Company
• JAK inhibitor ‘Olumiant’ seeks reimb for atopic dermatitis
• by Eo, Yun-Ho Jun 18, 2021 05:54am